Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
| ▸ | LIPC | P11150 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7030578 | 1.00 | MRGPRX4 (0.47) | MRGPRX4KDM4CALDH1A1KDM4EHPGD | |
| SCHEMBL421273 | 0.88 | KDM4E (0.56) | MRGPRX4KDM4CALDH1A1KDM4EHPGD | |
| SCHEMBL7029353 | 0.87 | CA12 (0.44) | MRGPRX4ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL7029347 | 0.87 | CA12 (0.44) | MRGPRX4ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL7025132 | 0.83 | CA1 (0.47) | ALDH1A1KDM4EHPGDHSD17B10CA12 | |
| SCHEMBL7025130 | 0.83 | CA1 (0.47) | ALDH1A1KDM4EHPGDHSD17B10CA12 | |
| SCHEMBL3019598 | 0.82 | PTGDR2 (0.58) | MRGPRX4KDM4CALDH1A1KDM4EHPGD | |
| SCHEMBL420174 | 0.82 | PTGDR2 (0.54) | MRGPRX4KDM4CALDH1A1KDM4EHPGD | |
| SCHEMBL3024092 | 0.81 | PTGDR2 (0.60) | MRGPRX4KDM4CALDH1A1KDM4EHPGD | |
| SCHEMBL7026057 | 0.80 | CA1 (0.47) | KDM4CALDH1A1KDM4ECA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030088113-A1 | Process for preparing resorcinol derivatives | BRADLEY STUART EDWARD (GB) | 2003-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030088113-A1 | Process for preparing resorcinol derivatives | CYP4B1, CYP4A11, POR | MRGPRX4 2709/4885KDM4C 916/4885ALDH1A1 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.